Toolkit: Water purity in pharma and healthcare
Take the quiz and journey through the interactive tool to find out about water purity in healthcare and pharma.
List view / Grid view
Take the quiz and journey through the interactive tool to find out about water purity in healthcare and pharma.
Learn how the pharma supply chain is evolving, the role of real-time data in critical cold chain shipments and how to increase & improve visibility.
This guide explores critical concepts that supply chain professionals need to know about tracking and analysing cold chain pharmaceutical shipments.
Learn why water purity matters in this essential guide to HPLC in pharma analysis. Find out how to deal with water-related issues in drug manufacture, analysis and QC.
What are the top six challenges facing pharmaceutical and biopharmaceutical manufacturers in 2022? We spoke to representatives from four contract manufacturing and development organisations (CDMOs) – Samsung Biologics, Lonza, MedPharm and Genezen – to find out.
New solution improves machine efficiency, prevents breakdowns, lowers costs and reduces risks whilst providing anytime, anywhere remote monitoring.
In 20 years BIOCAD grew from a pharma startup outside of Moscow to an international company producing both biosimilars and original products.
Population pharmaceutical quality assessment could be used to improve the quality consistency of generic drugs, suggests study.
Our customised microbial solutions ensure your cleanroom is compliant and free of contamination to manufacture safe and effective products.
This webinar shares study data, research experience and best practices to mitigate the risks of single-use bags in the frozen distribution steps.
Linda De Jesus, Senior Vice President and Chief Commercial Officer at Azenta Life Sciences highlights the benefits of uniting and focusing efforts solely for the life sciences sector.
Tim Mullane, President and COO of FUJIFILM Irvine Scientific, talks expansion, evolution and excellence.
Killian O’Driscoll, Director of Projects at the National Institute for Bioprocessing Research and Training (NIBRT), highlights the plight of a future skills shortage in the global biopharma industry as state-of-the-art therapy production evolves at a rapid pace.
Healthcare groups including the US Pharmacopeia and American Medical Association release advice for policymakers on addressing challenges in the US supply chain.
When you are reviewing bacterial and fungal isolates, do you appreciate that the names given to these organisms are regulated?